Skip to main content

Publisher: Palgrave Macmillan

Volume 12, Number 4, 1 July 2006

Editorial
pp. 253-253(1)
Author: Henderson, Neil

Favourites:
ADD

Valuing biotechnology companies using the price earnings ratio
pp. 254-260(7)
Authors: Loh, Jacqueline; Brooks, Robert

Favourites:
ADD
Favourites:
ADD

Ticking time bomb: Poorly managed product safety
pp. 284-293(10)
Authors: Meline, Greg; Albani, Chris

Favourites:
ADD

Cancer remains the dominant disease target for biotech through to 2010
pp. 294-298(5)
Authors: Pijpers, Fleur; Belsey, Mark J

Favourites:
ADD

Legal and regulatory update
pp. 299-311(13)

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more